Vitamin D

Studies of vitamin D in people

397 studies gave vitamin D to people and measured what changed

What changedDesignPeopleSource

down: Decreases fasting blood glucose112.6 ± 8.4 to 102.4 ± 7.3 mg/dL; greater improvement than controls, P < 0.001

up: Increases 25-hydroxyvitamin D18.4 ± 4.5 to 27.6 ± 2.8 ng/mL

Trial3 months90 people18-65 yearsAdults with prediabetes; supplementation plus lifestyle advice compared with lifestyle advice aloneThe Nigerian postgraduate medical journal, Nov 2, 2026

down: Lowers the risk of mortalityRR = 0.96 (95% CI [0.92, 1.00], p = 0.04)

Review of trials2 and 6.1 years30,320 people pooledminimum age of 50 yearsPopulation aged over 75 yearsFundamental & clinical pharmacology, Oct 2, 2026

no change: Has no effect on plasma ADRD biomarkers

down: Decreases NfL-16.2% (95% CI: −30.5% to 1.1%)

Randomized trial4‐year929 people49.2% were femalesmean age was 65 yearsVITAL participants who lived near an affiliated National Institutes of Health–sponsored Harvard Catalyst–Clinical Translational Science Center in Boston, MassachusettsAlzheimer's & dementia (New York, N. Y.), Sep 14, 2026

down: Decreases fasting blood glucose

down: Decreases insulinMD = −0.30; 95% CI –0.56 to −0.03

down: Decreases HOMA-IRMD = −2.82; 95% CI, –5.06 to −0.57

Review of trialsAdults with prediabetesNutrition reviews, Sep 10, 2026

up: Increases 25-hydroxyvitamin DP < 0.01

Trial24-month520 peopleaged ≥65 yearsOlder adultsPreventive Medicine Research & Reviews, Sep 8, 2026

up: Raises the risk of fracture riskHR 1.52, 95% CI 1.06-2.18

no change: Has no effect on fracture riskHR 1.07, 95% CI 0.72-1.58

up: Increases 25-hydroxyvitamin D73.0 vs 99.7 vs 120.4 nmol/L

Randomized trialmean 4.1-year550 peopleBothmen ≥60 years and women ≥65 yearsOlder adultsBone, Sep 7, 2026

up: Improves cognitive function

Randomized trial12 months360 peopleolder adultsOlder adults; Patient cohortsNutrients, Aug 25, 2026

down: Decreases allostatic loadadjusted difference −0.54, p<0.001

down: Decreases perceived stressFDR-adjusted p<0.01

no change: Has no effect on blood pressure

Randomized trial125 peopleGeneral population; in conflict-exposed adultsPreprints.org, Aug 11, 2026

up: Increases 25-hydroxyvitamin D38.2 ± 7.5 ng/mL vs 28.5 ± 6.8 ng/mL

up: Increases femoral neck bone mineral density2.8% ± 1.2% vs 1.1% ± 0.9%

up: Increases lumbar spine bone mineral density2.8% ± 1.2% vs 1.1% ± 0.9%

Randomized trial24 months153 peopleWomen50-75 yearsPostmenopausal women; Older adults; T-scores -1.5 to -2.5European journal of clinical nutrition, Aug 7, 2026

down: Decreases C-reactive proteinMD: -0.98 μg/mL

up: Increases total antioxidant capacityMD: +0.60 mmol/L

down: Decreases fasting blood glucoseMD: -22.83 mg/dL

Randomized trial8 weeks104 peopleelderlyOlder adults; cosupplementation with flaxseed oil in elderly patients with T2DMJournal of nutrition and metabolism, Jul 29, 2026

up: Increases 25-hydroxyvitamin D

down: Decreases parathyroid hormone

Randomized trial10 weeks50 people>65 yearsOlder adults; vitamin D deficiencyIndian Journal of Orthopaedics Surgery, Jul 24, 2026

up: Improves physical functionP < 0.05

Randomized trial10 weeks50 peopleWomen24.90 ± 4.61 yearsOsteosarcoma after bone marrow stem cell transplantationComparative Exercise Physiology, Jul 23, 2026

up: Increases 25-hydroxyvitamin D

up: Increases HDL cholesterol

down: Decreases systolic blood pressure

Trial24 months34 peopleWomenmean of 63.8 ± 7.5 yearsOlder adults; Postmenopausal women; postmenopausal women with T2DMDiabetology, Jul 6, 2026

no change: Has no effect on areal bone mineral density

Randomized trial2 years771 peopleJBMR plus, Jul 3, 2026

no change: Has no effect on vitamin K status

Randomized trial8 weeks200 peopleGeneral populationFrontiers in nutrition, Jun 30, 2026

no change: Has no effect on handgrip strength0.07 ± 3.40 kg (cholecalciferol) and -0.19 ± 3.35 kg (control), P = .682

up: Increases 25-hydroxyvitamin D89.78 ± 33.43 nmol/L at 6 months

no change: Has no effect on frailty

Randomized trial6 months143 peopleIn vitamin D-deficient hemodialysis patients with 25OHD ≤50 nmol/LClinical kidney journal, May 21, 2026

down: Decreases P1NP-3.3% (95% CI -5.6, -1.0)

down: Decreases CTX-3.8% (95% CI -6.8, -0.8)

up: Increases 25-hydroxyvitamin D

Review of trials2,654 people pooledOlder adultsThe British journal of nutrition, Apr 27, 2026

up: Improves 6-minute walk distancep<0.05

no change: Has no effect on ventilatory variables

Randomized trial26 weeks40 peopleMen40 to 80 yearsMidlife adults; Older adults; vitamin D3 deficient stable COPDMymensingh medical journal : MMJ, Mar 31, 2026

up: Improves neuromuscular performancep<0.05

up: Increases vitamin Dp<0.05

Randomized trial12 weeks60 people60-75 yearsOlder adults; vitamin D insufficiencyGeriatric Care, Mar 24, 2026

up: Improves FEV1Δ0.18 ± 0.08 L

up: Increases 25-hydroxyvitamin Dp < 0.001

Randomized trial12 weeks30 people30-55 yearsMidlife adults; mild to moderate asthmaThe Journal of asthma : official journal of the Association for the Care of Asthma, Mar 20, 2026

up: Increases gait speedSMD 1.44 (95% CI 0.76 to 2.11)

Review of trials3,063 people pooledelderlyOlder adults; network meta-analysis in older adults with sarcopeniaComplementary therapies in medicine, Mar 6, 2026

up: Increases 25-hydroxyvitamin D10.67 ± 8.16 vs. –1.29 ± 3.96 ng/mL

up: Increases adiponectin1.38 ± 3.05 vs. 0.34 ± 1.89 μg/mL

down: Decreases C-reactive protein–6.74 ± 14.65 vs. 1.81 ± 7.75 mg/L

Randomized trial12 weeks40 peopleadultIn adult epilepsy patients treated with enzymatic antiseizure medicationsMedicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina, Feb 27, 2026

no change: Has no effect on hypertensionHR 1.00; 95% CI 0.93 to 1.08

no change: Has no effect on hypercholesterolemiaHR 1.05; 95% CI 0.97 to 1.13

no change: Has no effect on type 2 diabetesHR 0.97; 95% CI 0.84 to 1.12

Randomized trial4.6 years10,964 peopleBoth60-84 yearsOlder adultsNutrients, Jan 22, 2026

no change: Has no effect on risk of falls55% vs 55% vs 55%

up: Increases 25-hydroxyvitamin D100 and 120 vs 73 nmol/L

Randomized trial5 years2,495 peopleBothmen aged ≥ 60 and women aged ≥ 65Older adultsJournal of the American Geriatrics Society, Jan 13, 2026

up: Increases 25-hydroxyvitamin Dp < 0.001

no change: Has no effect on muscle mass

Randomized trial12 weeks46 peopleWomenelderlyOlder adultsClinics (Sao Paulo, Brazil), Jan 1, 2026

up: Increases 25-hydroxyvitamin D+86.84% from baseline; discussion reports 84%

down: Decreases fasting and 2-hour blood glucose

no change: Has no effect on HOMA-IR

Randomized trial3 months123 peopleWomen16 to 40 yearsPolycystic ovary syndromeReviews on recent clinical trials, Jan 1, 2026

up: Increases gait instability

Randomized trial20 weeks161 peopleolder adultsOlder adults; mild cognitive impairmentGSA 2025 abstract, Dec 31, 2025

up: Increases gait instability

Randomized trial20 weeks161 peopleolder adultsOlder adults; in older adults with MCIGSA 2025 abstract, Dec 31, 2025

up: Increases appendicular skeletal muscle mass index

up: Improves physical function

up: Improves quality of life

Randomized trial12 weeks84 people47 males [56.0%] and 37 females [44.0%]mean [SD] age, 52.8 [15.9] yearsPatients aged between 18 and 70 years with CIF and serum 25(OH)D levels < 30.0 ng/mlJournal of translational medicine, Dec 25, 2025

no change: Has no effect on executive functionbetween-group difference: 5770, 95% CI: -2189 to 13730

no change: Has no effect on cognitive function

Randomized trial24-month620 people50 years or olderOlder adults; mild to moderate vitamin D deficiency and early cognitive impairmentAAIC 2025 abstract, Dec 23, 2025

down: Impairs global cognitionp = 0.03

Randomized trial6 months67 peopleBothmean age: 73.8 yearsOlder adults; mild cognitive impairmentAAIC 2025 abstract, Dec 23, 2025

up: Increases 1,25-dihydroxyvitamin D3

Randomized trial3 months64 people≥65 yearsElderly residents in long-term care facilitiesNutrients, Dec 3, 2025

up: Increases 25-hydroxyvitamin D23.4 ± 10.1 to 33.9 ± 11.0 ng/mL

no change: Has no effect on leptin24.4 ± 18.3 vs. 21.9 ± 13.5 ng/mL; p = 0.215

no change: Has no effect on IL-6

Trial16 weeks33 peopleWomenOrthodox nuns practicing intermittent fastingFrontiers in endocrinology, Nov 26, 2025

no change: Has no effect on body composition

no change: Has no effect on 25(OH)D

Randomized trial12 weeks40 peopleBothaged 60 or olderOlder adultsInternational journal of environmental research and public health, Nov 10, 2025

up: Increases 25-hydroxyvitamin D38.2 vs. 35.2 ng/mL

down: Decreases parathyroid hormone43.5 vs. 75.2 pg/mL, p = 0.001

Randomized trial5 days or 5 weeks50 peopleBoth≥ 75 yearsOlder adults; The oldest old; post-hip fracture surgeryEuropean geriatric medicine, Sep 15, 2025

up: Increases gait variabilitymean difference = −0.63%, 95% CI: −1.22, −0.03

Randomized trial20-week175 people83 (51.6%) femalemean (SD) age, 73.1 (6.6) yearsOlder adults with MCIAge and ageing, Aug 29, 2025

up: Improves muscle mass

up: Improves physical function

up: Increases 25-hydroxyvitamin D

Trial6 months115 people71.3% were female, and 28.7% were malemean age of 63.2 ± 9.6 yearsPatients aged 50–80 years who were diagnosed with degenerative lumbar diseaseClinical and translational science, Aug 1, 2025

up: Improves handgrip strength

Randomized trial8 weeks44 peoplewomen65.3 ± 3.4 yearsPostmenopausal women with obesity or overweight and insufficient/deficient serum 25(OH)D levelsWomen's health (London, England), Jul 30, 2025

up: Increases telomere length

Randomized trial18 months121 peoplewomenAsian Indian women with prediabetesJournal of the Endocrine Society, Jul 8, 2025

no change: Has no effect on bone mineral density

up: Increases 25-hydroxyvitamin D

Randomized trialWithin 2 weeks and approximately 4 years after delivery443 peopleWomenPregnancy supplementation compared with placeboOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, Jun 23, 2025